Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are found to harbor disseminated tumor cells (DTCs) in the bone marrow after definitive surgery and standard adjuvant therapy.
Epistemonikos ID: e869a957380d80949f28770932852e69a7d7e3f1
First added on: May 08, 2024